Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients’ teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.
1997
20.9K+
LTM Revenue $4.1B
LTM EBITDA $1.0B
$12.4B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Align Technology has a last 12-month revenue (LTM) of $4.1B and a last 12-month EBITDA of $1.0B.
In the most recent fiscal year, Align Technology achieved revenue of $4.0B and an EBITDA of $817M.
Align Technology expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Align Technology valuation multiples based on analyst estimatesLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Revenue | $4.1B | XXX | $4.0B | XXX | XXX | XXX |
Gross Profit | $2.9B | XXX | $2.8B | XXX | XXX | XXX |
Gross Margin | 70% | XXX | 70% | XXX | XXX | XXX |
EBITDA | $1.0B | XXX | $817M | XXX | XXX | XXX |
EBITDA Margin | 26% | XXX | 20% | XXX | XXX | XXX |
EBIT | $895M | XXX | $672M | XXX | XXX | XXX |
EBIT Margin | 22% | XXX | 17% | XXX | XXX | XXX |
Net Profit | $722M | XXX | $421M | XXX | XXX | XXX |
Net Margin | 18% | XXX | 11% | XXX | XXX | XXX |
Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Align Technology's stock price is $181.
Align Technology has current market cap of $13.1B, and EV of $12.4B.
See Align Technology trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$12.4B | $13.1B | XXX | XXX | XXX | XXX | $9.73 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Align Technology has market cap of $13.1B and EV of $12.4B.
Align Technology's trades at 3.1x EV/Revenue multiple, and 15.1x EV/EBITDA.
Equity research analysts estimate Align Technology's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Align Technology has a P/E ratio of 18.2x.
See valuation multiples for Align Technology and 12K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Market cap (current) | $13.1B | XXX | $13.1B | XXX | XXX | XXX |
EV (current) | $12.4B | XXX | $12.4B | XXX | XXX | XXX |
EV/Revenue | 3.0x | XXX | 3.1x | XXX | XXX | XXX |
EV/EBITDA | 11.9x | XXX | 15.1x | XXX | XXX | XXX |
EV/EBIT | 13.8x | XXX | 18.4x | XXX | XXX | XXX |
EV/Gross Profit | 4.3x | XXX | n/a | XXX | XXX | XXX |
P/E | 18.2x | XXX | 31.1x | XXX | XXX | XXX |
EV/FCF | 19.7x | XXX | 19.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialAlign Technology's last 12 month revenue growth is 5%
Align Technology's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Align Technology's rule of 40 is 25% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Align Technology's rule of X is 37% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Align Technology and other 12K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Revenue Growth | 5% | XXX | 5% | XXX | XXX | XXX |
EBITDA Margin | 26% | XXX | 20% | XXX | XXX | XXX |
EBITDA Growth | 7% | XXX | 16% | XXX | XXX | XXX |
Rule of 40 | 25% | XXX | 25% | XXX | XXX | XXX |
Bessemer Rule of X | XXX | XXX | 37% | XXX | XXX | XXX |
Revenue per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
R&D Expenses to Revenue | XXX | XXX | 9% | XXX | XXX | XXX |
Opex to Revenue | XXX | XXX | 53% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Philips | XXX | XXX | XXX | XXX | XXX | XXX |
Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Align Technology acquired XXX companies to date.
Last acquisition by Align Technology was XXXXXXXX, XXXXX XXXXX XXXXXX . Align Technology acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free TrialWhen was Align Technology founded? | Align Technology was founded in 1997. |
Where is Align Technology headquartered? | Align Technology is headquartered in United States of America. |
How many employees does Align Technology have? | As of today, Align Technology has 20.9K+ employees. |
Who is the CEO of Align Technology? | Align Technology's CEO is Mr. Joseph M. Hogan. |
Is Align Technology publicy listed? | Yes, Align Technology is a public company listed on NAS. |
What is the stock symbol of Align Technology? | Align Technology trades under ALGN ticker. |
When did Align Technology go public? | Align Technology went public in 2001. |
Who are competitors of Align Technology? | Similar companies to Align Technology include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
What is the current market cap of Align Technology? | Align Technology's current market cap is $13.1B |
What is the current revenue of Align Technology? | Align Technology's last 12 months revenue is $4.1B. |
What is the current revenue growth of Align Technology? | Align Technology revenue growth (NTM/LTM) is 5%. |
What is the current EV/Revenue multiple of Align Technology? | Current revenue multiple of Align Technology is 3.0x. |
Is Align Technology profitable? | Yes, Align Technology is EBITDA-positive (as of the last 12 months). |
What is the current EBITDA of Align Technology? | Align Technology's last 12 months EBITDA is $1.0B. |
What is Align Technology's EBITDA margin? | Align Technology's last 12 months EBITDA margin is 26%. |
What is the current EV/EBITDA multiple of Align Technology? | Current EBITDA multiple of Align Technology is 11.9x. |
What is the current FCF of Align Technology? | Align Technology's last 12 months FCF is $628M. |
What is Align Technology's FCF margin? | Align Technology's last 12 months FCF margin is 15%. |
What is the current EV/FCF multiple of Align Technology? | Current FCF multiple of Align Technology is 19.7x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.